Promoter Hypomethylation Results in Increased Expression of Protein Phosphatase 2A in T Cells from Patients with Systemic Lupus Erythematosus

The catalytic subunit α isoform of protein phosphatase 2A (PP2Acα) activity, protein, and mRNA have been found increased in systemic lupus erythematosus (SLE) T cells and to contribute to decreased IL-2 production. The PP2Acα promoter activity is controlled epigenetically through the methylation of a CpG within a cAMP response element (CRE) motif defined by its promoter. We considered that hypomethylation may account for the increased expression of PP2Acα in patients with SLE. Using bisulfite sequencing, we found that SLE T cells displayed decreased DNA methylation in the promoter region compared with normal T cells. More importantly, we found that the CRE-defined CpG, which binds p-CREB, is significantly less methylated in SLE compared with normal T cells, and the levels of methylation correlated with decreased amounts of DNA methyltransferase 1 transcripts. Methylation intensity correlated inversely with levels of PP2Acα mRNA and SLE disease activity. Chromatin immunoprecipitation assays revealed more binding of p-CREB to the CRE site in SLE T cells, resulting in increased expression of PP2Acα. We propose that PP2Acα represents a new methylation-sensitive gene that, like the previously reported CD70 and CD11a, contributes to the pathogenesis of SLE.

[1]  A. Perl,et al.  Abnormal T cell signal transduction in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[2]  J. Harley,et al.  Unraveling the genetics of systemic lupus erythematosus , 2006, Springer Seminars in Immunopathology.

[3]  D. Virshup,et al.  Protein phosphatase 2A: a panoply of enzymes. , 2000, Current opinion in cell biology.

[4]  Mariana J. Kaplan,et al.  Demethylation of Promoter Regulatory Elements Contributes to Perforin Overexpression in CD4+ Lupus T Cells1 , 2004, The Journal of Immunology.

[5]  P. Jagodziński,et al.  MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population , 2007, Lupus.

[6]  Q. Lu,et al.  T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. , 2009, Clinical immunology.

[7]  G. Tsokos,et al.  Methylation Status of CpG Islands Flanking a cAMP Response Element Motif on the Protein Phosphatase 2Acα Promoter Determines CREB Binding and Activity1 , 2009, The Journal of Immunology.

[8]  Nam-Hee Kwon,et al.  DNA methylation and the expression of IL-4 and IFN-gamma promoter genes in patients with bronchial asthma. , 2008, Journal of clinical immunology.

[9]  J. Hansen,et al.  Recent Advances in Mecp2 Structure and Function Introduction: a Historical Perspective of Mecp2 Structure and Function , 2022 .

[10]  Y. Takasaki,et al.  DNA methylation: its contribution to systemic lupus erythematosus , 2006, Clinical and Experimental Medicine.

[11]  Yuanjia Tang,et al.  MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 , 2010, The Journal of Immunology.

[12]  G L Johnson,et al.  Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation , 1993, Molecular and cellular biology.

[13]  M. Vilardell‐Tarrés,et al.  Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus , 2008, Immunology.

[14]  G. Muszyńska,et al.  Protein phosphatase 2A: variety of forms and diversity of functions. , 2001, Acta biochimica Polonica.

[15]  A. Wolffe,et al.  How does DNA methylation repress transcription? , 1997, Trends in genetics : TIG.

[16]  G. Cooper,et al.  Occupational risk factors for the development of systemic lupus erythematosus. , 2004, The Journal of rheumatology.

[17]  R. Read,et al.  Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[18]  Christopher B Wilson,et al.  Epigenetic control of T-helper-cell differentiation , 2009, Nature Reviews Immunology.

[19]  B. Richardson,et al.  Role of DNA methylation in the regulation of cell function. , 1999, The Journal of laboratory and clinical medicine.

[20]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[21]  M. Nakao,et al.  Genomic imprinting: significance in development and diseases and the molecular mechanisms. , 1996, Journal of biochemistry.

[22]  Y. Khew-Goodall,et al.  Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. , 1991, Biochemistry.

[23]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[24]  G. Tsokos,et al.  PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. , 2008, Journal of immunology.

[25]  Q. Lu,et al.  Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus1 , 2007, The Journal of Immunology.

[26]  A. Sawalha,et al.  Impaired T Cell Protein Kinase Cδ Activation Decreases ERK Pathway Signaling in Idiopathic and Hydralazine-Induced Lupus1 , 2007, The Journal of Immunology.

[27]  Q. Lu,et al.  Demethylation of the Same Promoter Sequence Increases CD70 Expression in Lupus T Cells and T Cells Treated with Lupus-Inducing Drugs1 , 2005, The Journal of Immunology.

[28]  H. Shin,et al.  Association analyses of DNA methyltransferase-1 (DNMT1) polymorphisms with systemic lupus erythematosus , 2004, Journal of Human Genetics.

[29]  C. Matouk,et al.  Epigenetic Regulation of Vascular Endothelial Gene Expression , 2008, Circulation research.

[30]  P. Janson,et al.  CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes. , 2008, Journal of immunology.

[31]  B. Richardson,et al.  Aberrant T cell ERK pathway signaling and chromatin structure in lupus. , 2009, Autoimmunity reviews.

[32]  B. Richardson,et al.  Epigenetic mechanisms in lupus , 2010, Current opinion in rheumatology.

[33]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[34]  A. Schönthal,et al.  Autoregulation of Protein Phosphatase Type 2A Expression* , 1998, The Journal of Biological Chemistry.

[35]  N. Knowlton,et al.  Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients , 2008, Genes and Immunity.

[36]  F. Zeng,et al.  Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients , 2008, Acta Pharmacologica Sinica.

[37]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[38]  S. Akira,et al.  Requirement for DNA CpG Content in TLR9-Dependent Dendritic Cell Activation Induced by DNA-Containing Immune Complexes1 , 2009, The Journal of Immunology.

[39]  Q. Lu,et al.  Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. , 2010, Journal of autoimmunity.

[40]  J. Harley,et al.  Antinuclear autoantibodies in systemic lupus erythematosus , 2004, Current opinion in rheumatology.

[41]  P. Janson,et al.  CpG Methylation of the IFNG Gene as a Mechanism to Induce Immunosupression in Tumor-Infiltrating Lymphocytes1 , 2008, The Journal of Immunology.

[42]  Zhiyong Zhang,et al.  Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. , 2003, Arthritis & Rheumatism.

[43]  Nam-Hee Kwon,et al.  DNA Methylation and the Expression of IL-4 and IFN-γ Promoter Genes in Patients with Bronchial Asthma , 2008, Journal of Clinical Immunology.

[44]  A. Sawalha,et al.  Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. , 2009, Translational research : the journal of laboratory and clinical medicine.

[45]  D. Gutsch,et al.  Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[46]  G. Tsokos,et al.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. , 2005, The Journal of clinical investigation.

[47]  P. Molloy,et al.  DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.

[48]  P. Jagodziński,et al.  Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. , 2004, Journal of applied genetics.

[49]  G. Tsokos,et al.  PP2A Dephosphorylates Elf-1 and Determines the Expression of CD3ζ and FcRγ in Human Systemic Lupus Erythematosus T Cells1 , 2008, The Journal of Immunology.

[50]  J. Götz,et al.  Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice. , 2006, Biochemical and biophysical research communications.

[51]  A. Jeltsch,et al.  Biochemistry and biology of mammalian DNA methyltransferases , 2004, Cellular and Molecular Life Sciences CMLS.

[52]  J. Hofsteenge,et al.  Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A. , 1987, Biochemistry.

[53]  S. Hanash,et al.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. , 1988, Journal of immunology.

[54]  S. Hanash,et al.  Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[55]  H. Hashimoto,et al.  Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. , 2003, Clinical and experimental rheumatology.

[56]  K. Aho,et al.  Twin studies in rheumatic diseases. , 1994, Seminars in arthritis and rheumatism.

[57]  J. Pers,et al.  Epigenetics and autoimmunity. , 2010, Journal of autoimmunity.

[58]  M. Bartolomei,et al.  Genomic imprinting in mammals. , 1997, Annual review of genetics.

[59]  Xiangpei Li,et al.  Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic lupus erythematosus inhibits DNA methylation , 2009, Lupus.

[60]  Shizhong Han,et al.  Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus , 2008, PloS one.

[61]  A. Sawalha Epigenetics and T-cell immunity , 2008, Autoimmunity.

[62]  B. Richardson,et al.  Environmentally induced autoimmune diseases: potential mechanisms. , 1999, Environmental health perspectives.

[63]  Andrew I Su,et al.  Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. , 2003, Molecular cell.

[64]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[65]  Fatima Al-Shahrour,et al.  Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.

[66]  S. Hanash,et al.  Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. , 2001, Arthritis and rheumatism.